D. Keith Grossman - 09 Mar 2026 Form 4 Insider Report for MiniMed Group, Inc. (MMED)

Reporting relationship
Director
Issuer ticker
MMED
Reported as of
09 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Mar 2026, 16:31:15 UTC
Prior SEC filing
06 Mar 2026
Next SEC filing
05 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bryan F. Kelly, attorney-in-fact

Key filing fact

D. Keith Grossman filed Form 4 for MiniMed Group, Inc. (MMED) on 11 Mar 2026.

Key facts

  • This page summarizes D. Keith Grossman's Form 4 filing for MiniMed Group, Inc. (MMED).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Mar 2026, 16:31.

Change

  • Previous filing in this sequence was filed on 06 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001218702 Primary reporting owner

GROSSMAN D KEITH

Relationship
Director
Address
C/O 18000 DEVONSHIRE STREET, NORTHRIDGE
Signature
/s/ Bryan F. Kelly, attorney-in-fact
Signature date
11 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMED transaction

Common Stock

Award

Transaction value
Shares
+13,889
Change %
Price
$0.000000*
Shares after
13,889
Date
09 Mar 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units that vest on the one-year anniversary of the grant date.

Footnote F2

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .